Abstract Around 10% to 20% of all cases of acquired hyperpigmentation are drug-induced.
The underlying pathogenesis for drug-induced pigmentation includes melanin …

Drug-induced pigmentation occurs in up to 20% of acquired pigmentary disorders of the
skin. Association of its occurrence was reported in certain drugs, including …

Drug-induced pigmentation accounts for up to 20% of all cases of acquired pigmentation. A
thorough review of medical history and previous and ongoing medications as well as a …

Drug-induced pigmentation represents 10 to 20% of all cases of acquired
hyperpigmentation and this hypothesis must be systematically raised in unexplained …

Several medications have been implicated in drug-induced pigmentation, with evidence for
the association primarily derived from case reports. The incidence rates of drug-induced …

Medications have long been known to cause pigmentary changes of the skin. While this
frequently occurs as post-inflammatory changes of a resolving drug-induced rash …

Objectives: Identify the etiology of drug-induced pigmentation. Review the history and
physical exam of a patient with drug-induced pigmentation. Summarize the treatment and …

Exposure to a variety of pharmacologic agents can result in pigmentary changes involving
the skin, nails, hair, and mucous membranes. Although typically benign, the …

Fixed drug eruption typically presents one to two weeks after initiating drug therapy, but
sensitization may require a few weeks to several years of drug exposure (Korkij and Soltani …

Several categories of chemical and pharmacologic agents can cause alterations in
cutaneous pigmentation, although the mechanisms differ and in several instances may be …